Summary
This 10-K/A filing from Johnson & Johnson, filed in June 1996, pertains to the fiscal year ending December 31, 1994. As an amendment, it likely contains corrections or updates to previously filed information, but the core financial performance for 1994 would be the primary focus for investors. Investors should look for details on the company's revenue, profitability, and key operational segments, such as pharmaceuticals, medical devices, and consumer health products, as these would illustrate the company's market position and growth trajectory during that period. Despite the filing date being in 1996, the financial data is from 1994, which is crucial for historical analysis. Investors would be interested in understanding any significant trends, acquisitions, divestitures, or challenges that impacted JNJ's performance in 1994. The document is essential for evaluating the company's financial health and strategic direction leading up to the mid-1990s, providing context for its subsequent performance and market leadership.
Key Highlights
- 1Filing is an amendment (10-K/A) to the annual report for the fiscal year ending December 31, 1994.
- 2The filing date is June 27, 1996, indicating it's an updated or corrected filing for historical data.
- 3The report pertains to Johnson & Johnson (JNJ), a major healthcare company.
- 4As an amendment, it suggests that initial disclosures may have required revision, which investors should note.
- 5Key financial and operational details for the 1994 fiscal year are the primary subject matter.
- 6Investors can use this filing to assess JNJ's performance and financial standing in the mid-1990s.